Literature DB >> 9126223

Progress in standardization of immunoassays for prostate-specific antigen.

T A Stamey1.   

Abstract

A calibrator composed of 90% prostate-specific antigen-alpha 1-antichymotrypsin (PSA-ACT) and 10% free PSA reduces the variation in control serums with widely divergent amounts of free PSA, from a mean of 28% among nine different assays to 9% after recalibration. The lyophilized form of the Stanford 90:10 calibrator is stable and therefore an excellent candidate for international standardization of PSA assays.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126223     DOI: 10.1016/s0094-0143(05)70372-4

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  2 in total

1.  Assays for complexed prostate-specific antigen and other advances in the diagnosis of prostate cancer.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2003

2.  Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels.

Authors:  R M Hoffman; D L Clanon; B Littenberg; J J Frank; J C Peirce
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.